Questionnaires

Questionnaires

 

A questionnaire is an instrument designed to assess (some of) the different aspects that define the QoL of (a specific group of) cancer patients.

 

Conditions of use for Academic Users

If your study is purely for academic use, you will be required to have an Academic User Agreement in order to use our measures. An Academic User Agreement is required for each study and requires no fee.

In order to be able to use the QLQ-C30 and modules you need to obtain the permission via our download process below. By completing the process you are authorised to use the questionnaire in the study you mentioned. For each new study, you will have to enter a new download request.

 

Conditions of use for Commercial Users

If your study has commercial sponsorship you will be required to have a Commercial User Agreement in order to use our measures. A Commercial User Agreement is required for each study and a fee is requested dependent on the number of patients in the study.

For further details for commercial use, please contact us.

 

How to know if you are considered as a Commercial User or an Academic User?

If you are unsure of whether you are a commercial user or an academic user , please refer to our Terms and Conditions.

List of questionnaires

Code Name
QLQ-C30 Quality of Life of Cancer Patients Core validated validated
AYA Adolescents and Young Adults Core I / II - in development In development
QLQ-ANL27 Anal Cancer Module IV - in development Phase III completed
QLQ-BM22 Bone Metastases Module validated validated
QLQ-BN20 Brain Module validated validated
QLQ-BR23 Breast Module validated validated
QLQ-BR45 Breast Cancer (update of QLQ-BR23) Module IV - pending In development
QLQ-BRECON23 Breast Reconstruction Module validated validated
QLQ-CAX24 Cancer Cachexia Module IV - in development Phase III completed
QLQ-FA12 Cancer related Fatigue Module validated validated
QLQ-CX24 Cervical Module validated validated
QLQ-CIPN20 Chemotherapy-Induced Peripheral Neuropathy Module III - completed Phase III completed
QLQ-BIL21 Cholangiocarcinoma and Gallbladder Cancer Module validated validated
QLQ-CLL17 Chronic Lymphocytic Leukaemia Module IV - in development Phase III completed
QLQ-CML24 Chronic Myeloid Leukaemia Module IV - in development Phase III completed
QLQ-CR29 Colorectal Module validated validated
QLQ-LMC21 Colorectal Liver Metastases Module validated validated
QLQ-COMU26 Communication Standalone IV - in development Phase III completed
QLQ-ELD14 Elderly Cancer Patients Module validated validated
QLQ-EN24 Endometrial Module validated validated
QLQ-IN-PATSAT32 Satisfaction with In-Patient Cancer Care Standalone validated validated
QLQ-STO22 Gastric Module validated validated
QLQ-H&N35 Head & Neck Module validated validated
QLQ-H&N43 Head & Neck Cancer (update of QLQ-H&N35) Module IV - completed Phase III completed
QLQ-HCC18 Hepatocellular Carcinoma Module validated validated
HCPS Hereditary Cancer Predisposition Syndrome Module I / II - in development In development
QLQ-HDC29 High-Dose Chemotherapy Module III - completed Phase III completed
QLQ-NHL-HG29 High Grade Non-Hodgkin’s Lymphoma Module IV - in development Phase III completed
QLQ-HL27 Hodgkin’s Lymphoma Module IV - in development Phase III completed
IADL IADL in Brain Tumor Patients Module III - in development In development
QLQ-INFO25 Information Module validated validated
QLQ-NHL-LG20 Low Grade Non-Hodgkin’s Lymphoma Module IV - in development Phase III completed
QLQ-LC13 Lung Module validated validated
QLQ-LC29 Lung Cancer (update of QLQ-LC13) Module IV - in development Phase III completed
QLQ-MEL38 Melanoma Module III - completed Phase III completed
QLQ-MY20 Multiple Myeloma Module validated validated
QLQ-BLM30 Muscle Invasive Bladder Cancer Module III - completed Phase III completed
QLQ-NPC42 Nasopharyngeal Carcinoma Module III - in development In development
QLQ-GINET21 Neuroendocrine Carcinoid Module validated validated
QLQ-NMIBC24 Non-Muscle-Invasive Bladder Cancer Module III - completed Phase III completed
QLQ-OES18 Oesophageal Module validated validated
QLQ-OG25 Oesophago-Gastric Module validated validated
QLQ-OPT30 Ophthalmic Cancer Module III - completed Phase III completed
QLQ-OH15 Oral Health Module validated validated
QLQ-OV28 Ovarian Module validated validated
QLQ-PAN26 Pancreatic Cancer Module III - completed Phase III completed
pNET Pancreatic Neuroendocrine Tumour Module I / II - in development In development
QLQ-PR25 Prostate Module validated validated
QLQ-C15-PAL Quality of Life in palliative cancer care patients Core validated validated
QLQ-PRT20 Radiation Proctitis Module validated validated
QLQ-PATSAT-C33 Satisfaction with Cancer Care – Core questionnaire Standalone IV - pending Phase III completed
QLQ-OUT-PATSAT7 Satisfaction with Out-Patient Cancer Care Standalone IV - pending Phase III completed
QLQ-SHQ22 Sexual Health Standalone IV - in development Phase III completed
SCC Spinal Cord Compression Module I / II - in development In development
QLQ-SWB32 Spiritual Wellbeing Standalone validated validated
SURV111 Survivorship Core III - in development In development
SBQ Symptom-based questionnaire Standalone III - in development In development
QLQ-TC26 Testicular Cancer Module IV - completed Phase III completed
QLQ-THY34 Thyroid Cancer Module IV - in development Phase III completed
QLQ-VU34 Vulva Cancer Module IV - pending Phase III completed

Disclaimer

You are about to leave the Quality of Life Group website.

Cancel Leave Quality of Life Group website